Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Phenol or laser: which works better for pilonidal sinus?

NCT ID NCT06721169

Disease control Sponsor: Mersin University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 22, 2026 · Updated 2 times

Summary

This study compares two minimally invasive treatments for pilonidal sinus disease: phenol injection and laser ablation. Researchers will track complications, hospital stay, and recovery time in 64 adults with uncomplicated pilonidal sinus. The goal is to find which method is safer and gets people back to daily life faster.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
phenol (sclerosing agent) and laser ablation (thermal energy)
What this could lead to
If successful, this could show which minimally invasive treatment is more effective for pilonidal sinus disease, helping patients recover faster with fewer complications.
What could go wrong
This is a small, early-stage observational study with only 64 participants, so results may not apply to everyone. Both treatments have risks like infection or incomplete healing.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 64 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2024

Expected to finish

Nov 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

This prospective observational study will be conducted at the Department of General Surgery, Mersin University Hospital between December 15, 2024 and December 15, 2025. The study population consists of adult patients (≥18 years old) diagnosed with pilonidal sinus disease who are scheduled for surgical intervention.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients aged 18 years and older with pilonidal sinus disease * Patients who have not had any previous treatment for pilonidal sinus disease * Patients with uncomplicated pilonidal sinus * Having been diagnosed with pilonidal sinus disease * Patients whose descriptive and clinical characteristics are recorded in their medical files * Those who have signed the Informed Voluntary Consent Form/Written Consent Form Exclusion Criteria: * Patients who have previously been treated for pilonidal sinus disease * Patients with complicated pilonidal sinus disease * Patients aged under 18 * Patients whose descriptive and clinical characteristics are not recorded in their file records * Those who have not signed the Informed Voluntary Consent Form/Written Consent Form

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pilonidal sinus disorder are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

pilonidal sinus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Pilonidal sinus disorder Pilonidal sinus treatment Surgical outcomes

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Mersin University

    RECRUITING

    Mersin, 33010, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.